Understanding the symptoms and impacts of living with metastatic pancreatic adenocarcinoma: a prospective, noninterventional qualitative study
This qualitative interview study uncovered previously unreported symptoms and impacts of mPC and supports the careful selection of appropriate PRO measures that more comprehensively reflect the experience of patients with mPC in future clinical trials.
Authors
- W. Park
- Rupali Fuldeore (ORCID: https://orcid.org/0000-0003-4336-9302)
- Lawrence Chang (ORCID: https://orcid.org/0000-0003-4117-1730)
- Eyra A. Perez
- Joanne S. Buzaglo (ORCID: https://orcid.org/0000-0002-1839-3047)
- Mok Oh (ORCID: https://orcid.org/0000-0002-6338-422X)
- C. Matney
- Yesne Alici
- Michelle Mao
Institutions
- ECRI Institute (US)
- Memorial Sloan Kettering Cancer Center (US)
- Cornell University (US)
- IQVIA (United Kingdom) (GB)
- IQVIA (United States) (US)
- The Institute of Addiction Medicine (US)
- Astellas Pharma (United States) (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1093/oncolo/oyaf427
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00